Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1753 - 1760 of 11454 results
Some Employee Chatter About Abortion Decision May Be Protected
July 12, 2022| News
White House Issues Telehealth Guidance on Substance Use Disorder Services
July 11, 2022| Blog| Viewpoint
Benefits of Using Copyrights to Protect Artificial Intelligence and Machine Learning Inventions
July 11, 2022| Blog| Viewpoint
Look Ahead: Upcoming Congressional Work Period – July 2022
July 11, 2022| Blog| Viewpoint
Health Insurance Maintenance During Massachusetts Paid Family and Medical Leave - Draft Regulations Issued
July 11, 2022| Blog| Viewpoint
Federal Circuit Affirms Right To Challenge Marks Without US Use
July 7, 2022| News
What’s New in 5G - July 2022
July 7, 2022| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.